COVID-19 Infection | Norton Healthcare

Indication: COVID-19 Infection

A Master Protocol Assessing The Safety, Tolerability, And Efficacy Of Anti Spike (S) Sars-Cov-2 Monoclonal Antibodies For The Treatment Of Hospitalized Patients With Covid-19

Sub-indication: COVID-19 Infection

Drug Study

Principal Investigator: Joseph Flynn, Physician-in-Chief NCI
Norton Cancer Institute

Sponsor: Regeneron Pharmaceuticals, Inc.

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.